Cochlear: Interim result 2016

The maker of hearing implants had a bumper first-half and is increasing its market share.

This time two years ago we upgraded Cochlear, believing it was a high-quality growth stock hit by a temporary setback as people held out for the latest model (see Cochlear: Interim result 2014 (Buy – $54.64)).

That investment case has played out, though it's starting to look as though we left some money on the table. Total revenue rose 32% in the six months to 31 December to $581m, or 16% after removing the effect of currency fluctuations.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles